Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin – a
VERTIS CV
sub‐study
2021 ◽
Vol 5
(Supplement_1)
◽
pp. A331-A331
2021 ◽
Vol 5
(Supplement_1)
◽
pp. A331-A332
2011 ◽
Vol 14
(1)
◽
pp. 30-39
◽
Keyword(s):